Synergistic antitumor effect of histone deacetylase inhibitor and Doxorubicin in peripheral T-cell lymphoma.
Leuk Res
; 56: 29-35, 2017 05.
Article
in En
| MEDLINE
| ID: mdl-28171799
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Doxorubicin
/
Lymphoma, T-Cell, Peripheral
/
Histone Deacetylase Inhibitors
Limits:
Humans
Language:
En
Journal:
Leuk Res
Year:
2017
Document type:
Article
Country of publication:
United kingdom